Melanie Keller

Melanie Keller is a seasoned professional in the biopharmaceutical sector, currently serving as Division Head Europe at Cancer Genetics, Inc. since August 2017. Prior to this role, Melanie held various positions at vivoPharm Pty Ltd from October 2008, including Division Head of vivoPharm Europe Limited, Team Leader, and Project Manager for Europe and the US East. Earlier experience includes working as a Clinical Research Associate I at GPC Biotech / Aggenix from January 2005 to October 2008, and as a Clinical Monitor at Ecron Acunova from January 1995 to December 1996. Academic qualifications include a Dr. rer. nat in Pharmacy from Ludwig-Maximilians-Universität München (2002-2005) and a Dipl. Biol. in Pharmaceutical Biology from the University of Konstanz (1994-2001).